HIDRADENITIS

Clinical trials for HIDRADENITIS explained in plain language.

Never miss a new study

Get alerted when new HIDRADENITIS trials appear

Sign up with your email to follow new studies for HIDRADENITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 2

Could anifrolumab be the next hope for HS patients?

Disease control Ongoing

This study tests whether anifrolumab, a drug that blocks certain immune processes, can help people with hidradenitis suppurativa (HS) — a painful skin condition causing boils and tunnels. About 15 adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks…

Matched conditions: HIDRADENITIS

Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

HIDRADENITIS

Get alerted when new HIDRADENITIS trials appear

Could anifrolumab be the next hope for HS patients?